THE MINISTER FOR HEALTH AND SOCIAL SERVICES, in pursuance of Articles 13 and 27 of the Misuse of Drugs (Jersey) Law 1978[1], orders as follows –

“SCHEDULE 1

(Article 1)

Schedule 1 DRUGS

1        The following substances and products –

(a)     Amphetamine

Bufotenine

Cannabinol

Cannabinol derivatives except dronabinol and except any sterio-isomer of dronabinol

Cannabis and cannabis resin

Cathinone

Coca leaf

Concentrate of poppy-straw

Eticyclidine

Etryptamine

Gammahydroxybutyrate

Lysergamide

Lysergide and other N-alkyl derivatives of lysergamide

Mescaline

Methcathinone

Methylamphetamine

Psilocin

Raw opium

Rolicyclidine

Tenocyclidine

4-Bromo-2,5-dimethoxy- a -methylphenethylamine

N,N-Diethyltryptamine

N,N-Dimethyltryptamine

2,5-Dimethoxy-a, 4-dimethylphenethylamine

N-Hydroxy-tenamphetamine

4-Methyl-aminorex;

(b)     any compound (not being a compound specified in sub-paragraph (a)) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c)     the following phenethylamine derivatives –

Allyl(a-methyl-3,4-methylenedioxyphenethyl)amine

2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

2-Amino-1-(3,4-dimethoxyphenyl)ethanol

Benzyl(a-methyl-3,4-methylenedioxyphenethyl)amine

4-Bromo-b,2,5-trimethoxyphenethylamine

N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

Cyclopropylmethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine

2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

2-(1,4-Dimethoxy-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

a,a-Dimethyl-3,4-methylenedioxyphenethylamine

a,a-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

Dimethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

2-Methoxyethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

b-Methoxy-3,4-methylenedioxyphenethylamine

1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

2-(a-Methyl-3,4-methylenedioxyphenethylamino)ethanol

a-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

N-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

O-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

a-Methyl-4-(methylthio)phenethylamine

b,3,4,5-Tetramethoxyphenethylamine

b,2,5-Trimethoxy-4-methylphenethylamine;

(d)     any compound (not being methoxyphenamine or a compound specified in sub-paragraph (a)) structurally derived from phenethylamine, an N-alkylphenethylamine, a methylphenethylamine, an N-alkyl- a-methylphenethylamine, a-ethylphenethylamine, or an N-alkyl- a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents;

(e)     any compound (not being a compound specified in Schedule 2) structurally derived from fentanyl by modification in any of the following ways –

(i)      by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle,

(ii)      by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups,

(iii)     by substitution in the piperidine ring with alkyl or alkenyl groups,

(iv)     by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups,

(v)     by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group,

(vi)     by replacement of the N-propionyl group by another acyl group;

(f)      any compound (not being a compound specified in Schedule 2) structurally derived from pethidine by modification in any of the following ways –

(i)      by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted,

(ii)      by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted,

(iii)     by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups,

(iv)     by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group,

(v)     by formation of an N-oxide or of a quaternary base;

(g)     1-benzylpiperazine;

(h)     any compound structurally derived from 1-benzylpiperazine or 1-phenylpiperazine by modification in either of the following ways –

(i)      by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl substituents,

(ii)      by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl substituents;

(i)      3,4-methylenedioxymethcathinone (Methylone);

(j)      3-keto-3,4-methylbenzodioxylbutanamine (Butylone);

(k)     4-methylmethcathinone (Mephedrone);

(l)      any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(m)    any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(n)     any compound structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(o)     any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent;

(p)     any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not substituted in the cyclohexyl ring to any extent.

2        Any stereoisomeric form of a substance specified in paragraph 1.

3        Any ester or ether of a substance specified in paragraph 1 or paragraph 2.

4        Any salt of a substance specified in any of paragraphs 1 to 3.

5        Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 4 not being a preparation specified in Schedule 5.”.

“SCHEDULE 2

(Article 1)

Schedule 2 DRUGS

1        The following substances and products –

Acetorphine

Alfentanil

Allylprodine

Alphacetylmethadol

Alphameprodine

Alphamethadol

Alphaprodine

Anileridine

Benzethidine

Benzylmorphine (3-benzylmorphine)

Betacetylmethadol

Betameprodine

Betamethadol

Betaprodine

Bezitramide

Carfentanil

Clonitazene

Cocaine

4-Cyano-2-dimethylamino-4,4-diphenylbutane

4-Cyano-1-methyl-4-phenylpiperidine

Desomorphine

Dextromoramide

Diamorphine

Diampromide

Diethylthiambutene

Difenoxin

Dihydrocodeinone O-carboxymethyloxime

Dihydroetorphine

Dihydromorphine

Dimenoxadole

Dimepheptanol

Dimethylthiambutene

Dioxaphetyl butyrate

Diphenoxylate

Dipipanone

Dronabinol

Drotebanol

Ecgonine and any derivative of ecgonine which is convertible to ecgonine or to cocaine

Ethylmethylthiambutene

Etonitazene

Etorphine

Etoxeridine

Fentanyl

Furethidine

Hydrocodone

Hydromorphinol

Hydromorphone

Hydroxypethidine

Isomethadone

Ketobemidone

Levomethorphan

Levomoramide

Levophenacylmorphan

Levorphanol

Lofentanil

Medicinal opium

Metazocine

Methadone

Methadyl acetate

Methyldesorphine

Methyldihydromorphine,(6-methyldihydromorphine)

1-Methyl-4-phenylpiperidine-4-carboxylic acid

2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid

a-Methylphenethylhydroxylamine

Metopon

Morpheridine

Morphine

Morphine methobromide, morphine N-oxide and other pentavalent nitrogen morphine derivatives

Myrophine

Nicomorphine

Noracymethadol

Norlevorphanol

Normethadone

Normorphine

Norpipanone

Oxycodone

Oxymorphone

Pethidine

Phenadoxone

Phenampromide

Phenazocine

Phencyclidine

Phenomorphan

Phenoperidine

4-Phenylpiperidine-4-carboxylic acid ethyl ester

Piminodine

Piritramide

Proheptazine

Properidine

Racemethorphan

Racemoramide

Racemorphan

Remifentanil

Sufentanil

Thebacon

Thebaine

Tilidate

Trimeperidine

Zipeprol.

2        Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan.

3        Any ester or ether of a substance specified in paragraph 1 or paragraph 2, not being a substance specified in paragraph 6.

4        Any salt of a substance specified in any of paragraphs 1 to 3.

5        Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.

6        The following substances and products –

Acetyldihydrocodeine

Buprenorphine

Codeine

Dextropropoxyphene

Diethylpropion

Dihydrocodeine

Ethylmorphine (3-ethylmorphine)

Fenethylline

Glutethimide

Lefatamine

Mecloqualone

Methaqualone

Methylphenidate

Nicocodine

Nicodicodine (6-nicotinoyldihydrocodeine)

Norcodeine

Pentazocine

Phenmetrazine

Phentermine

Pholcodine

Propiram

Quinalbarbitone.

7        Any steroeoisomeric form of a substance specified in paragraph 6.

8        Any salt of a substance specified in paragraph 6 or paragraph 7.

9        Any preparation or other product containing a substance or product specified in any of paragraphs 6 to 8, not being a preparation specified in Schedule 5.”